Pharmacometabolomics applied to low‐dose interleukin‐2 treatment in amyotrophic lateral sclerosis

Hugo Alarcan(Université de Tours), Hélène Blasco(Université de Tours), Christophe Masseguin(Centre Hospitalier Universitaire de Nîmes), Philippe Corcia(Centre Hospitalier Universitaire de Tours), Carey Suehs(Université de Montpellier), Ammar Al‐Chalabi(King's College London), Cecília Garlanda(Humanitas University), P. Nigel Leigh(University of Leeds), William Camu, Patrick Emond(Université de Tours), Timothy Tree(King's College London), John De Vos(Inserm), Andrea Malaspina(University College London), Patrick Vourc’h(Université de Tours), Raúl Juntas‐Morales(Université de Montpellier), Janine Kirby(University of Sheffield), Pamela J. Shaw(University of Sheffield), Clément Bruno(Centre Hospitalier Universitaire de Tours), Gilbert Bensimon(Pitié-Salpêtrière Hospital), Safaa Saker(Genethon (France)), Cédric Raoul(Centre National de la Recherche Scientifique), Jean‐Luc Veyrune(Université de Montpellier), Massimo Locati(Humanitas University)
Annals of the New York Academy of Sciences
May 21, 2024
Cited by 6


Related Papers